• AJMC
  • Center for BiosimilarsCenter for Biosimilars
AJMC
AJMC
Stakeholders
View MoreAcademiaEmployersHealth SystemPayersProviders
Topics
View MoreClinicalHealth Care CostHealth Care DeliveryInsurancePolicyTechnologyValue-Based Care
Institute for Value-Based Medicine
View MoreAll CoverageEvent CoverageInterviewsNews
About AJMC
AJMC JournalsAnniversaryAuthor FormsAuthorsNominate a Rising Leader
News
All News
Partners
Press Releases
Media
Clinical Spotlight
Enduring Webinars
Guidelines
Insights
Interviews
Medical World News
Microsites
OnLocation
Peer Exchange
Podcasts
Post Conference Perspectives
Sponsored
Stakeholder Summit
Week in Review
Conferences
Conference Coverage
Conference Listing
Journals
All Journals
The American Journal of Managed Care
The American Journal of Accountable Care
Evidence-Based Oncology
Evidence-Based Diabetes Management
Supplements and Featured Publications
Compendia
Breast Cancer
Chronic Kidney Disease
Clinical Pathways
COPD
Diabetes
Employers
Heart Failure
Hematology
HIV
Immuno-Oncology
Inflammation
Leukemia and Lymphoma
Lung Cancer
Migraine
Multiple Sclerosis
Oncology
Ophthalmology
Ovarian Cancer
Pain Management
Parkinson Disease
Precision Medicine in Oncology
Prostate Cancer
Pulmonary Arterial Hypertension
Rare Disease
Respiratory
Rheumatology
RNA Interference
Sleep
Spinal Muscular Atrophy
Events
Events
Upcoming Webinars
CME/CE
Resources
Exclusive Content
Formulary Central
Video Poster Detail
Subscribe
eNewsletter
  • About Us
  • Advertise
  • Contact
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2021 MJH Life Sciences and AJMC. All rights reserved.

Stakeholders
  • Academia
  • Employers
  • Health System
  • Payers
  • Providers
Topics
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Institute for Value-Based Medicine
  • All Coverage
  • Event Coverage
  • Interviews
  • News
About AJMC
  • AJMC Journals
  • Anniversary
  • Author Forms
  • Authors
  • Nominate a Rising Leader
  • About Us
  • Advertise
  • Contact
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.

Bret Jackson Outlines Findings, Origins, Next Steps of RAND Hospital Pricing Comparison Study

November 25, 2019

Conferences | National Alliance of Healthcare Purchaser Coalitions

A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.

A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.

Transcript

Michigan recently participated in a RAND study comparing hospital prices for privately insured patients to a Medicare benchmark. What were the results?

The results showed wide variation of hospital prices, especially outpatient prices, across the country. And it was really staggering what the differences were from state to state. Michigan actually fared pretty well in having some of the lowest prices in the country. However, we know that our premiums are above average for the states that are in the study and that total spending of healthcare is high in Michigan. And so, now that we know that prices are low, we know that the problem lies in utilization.

This was version 2.0 of the RAND study. What was the purpose of it and how did it differ from the 1.0 version? What is next?

They had done the study, they had just looked at Indiana, and then afterwards they were like, “Okay, well this seems like it’s high, but we have no idea how that compares to anybody else,” because they had no benchmark. So the 2.0 study was a 25-state study, looking at how Indiana compared to all the other states that participated. Now we’re trying to look at a 3.0 study, where we’re trying for a 50-state strategy so we can compare how everybody’s doing.